Golden State Equity Partners’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $68.5K | Buy |
11,430
+505
| +5% | +$3.03K | 0.02% | 355 |
|
|
2023
Q3 | $77.3K | Hold |
10,925
| – | – | 0.02% | 333 |
|
|
2023
Q2 | $76.9K | Hold |
10,925
| – | – | 0.02% | 365 |
|
|
2023
Q1 | $91.1K | Buy |
+10,925
| New | +$91.1K | 0.05% | 211 |
|
|
2022
Q1 | $186K | Hold |
11,435
| – | – | 0.09% | 181 |
|
|
2021
Q4 | $158K | Buy |
+11,435
| New | +$158K | 0.08% | 165 |
|